Mazen Alasadi, MD, FACG, FASGE
Department of Gastroenterology Hepatology and Nutrition, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Gastroenterology, Hepat,& Nutr, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Gastroenterology, Hepat,& Nutr, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 1988 | Damascus University, Damascus, SY, MD |
Postgraduate Training
| 1997-2000 | Clinical Fellowship, Gastroenterology, University of Kansas Medical Center, Kansas City, Kansas |
| 1991-1994 | Internship and Residency, Internal Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois |
Board Certifications
| 2001 | American Board of Gastroenterology, Hepatology |
| 1996 | American Board of Internal Medicine |
Experience & Service
Academic Appointments
Assistant Professor, Department of Gastroenterology, Hepat,& Nutr, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2024
Clinical Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, 2017 - 2018
Clinical Assistant Professor, Department of Gastroenterology, Hepat,& Nutr, Gulf Medical University, Ajman, 2013 - 2014
Chief of Gastroenterology and Hepatology, Department of Gastroenterology and Hepatology, Mafraq Hospital, Abu Dhabi, 2011 - 2014
Assistant Professor, Baylor College of Medicine, Houston, TX, 2003 - 2005
Administrative Appointments/Responsibilities
Patient Experience Officer, Department of Gastroenterology, Hepat,& Nutr, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Physician, Private Practice, Baytown, TX, 2005 - 2011
Physician, Kelsey-Seybold Clinic, Houston, TX, 2001 - 2005
Physician, St. Luke’s Episcopal Hospital, Houston, TX, 2001 - 2005
Physician, St. John’s Mercy Medical Group, Rolla, MO, 2000 - 2001
Physician, Woodland Community Hospital (underserved), Cullman, AL, 1994 - 1997
Physician, Addison Medical Clinic (underserved), Addison, AL, 1994 - 1997
Other Appointments/Responsibilities
Bi-Lingual Faculty Officer, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Gastroenterology Consultant, Cleveland Clinic Abu Dhabi (CCAD), Abu Dhabi, UAE, 2016 - 2018
Institutional Committee Activities
Member, HALs Gastroenterology, Hepatology, and Nutrition Business Committee, 2020 - Present
Member, MD Anderson Ambassador Events Committee, 2019 - Present
Member, HAL Procedures Steering Committee, 2019 - Present
Member, Faculty Incentive Planning Committee, 2019 - Present
Member, West Houston Shell Space Review for IR/Endoscopy Committee, 2019 - Present
Member, GI and Endoscopy Operations Planning Committee, 2019 - Present
Member, West Houston Campus Procedures and Anesthesiology Planning Committee, 2019 - Present
Honors & Awards
| Winner of Patient Experience Award West Houston Endoscopy 2020, The University of Texas MD Anderson Cancer Center | |
| Winner of Patient Experience Award West Houston Endoscopy 2021, The University of Texas MD Anderson Cancer Center | |
| Winner of Patient Experience Award West Houston Endoscopy 2022, The University of Texas MD Anderson Cancer Center |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Silva NN, Doan HQ, Alasadi M. Not all comedones are facial: Rare perianal lesions. Journal of Clinical Images and Medical Case Reports, 2022. PMID: None.
- Hollander B, Khurana S, Jacob JS, Altan M, Wang J, Zhao D, Varatharajalu K, Alasadi M, Thomas AS, Wang Y. Mesalamine and cholestyramine for immune checkpoint inhibitor-mediated diarrhea and colitis. J Cancer Res Clin Oncol. e-Pub 2022. PMID: 35972690.
- Dutra BES, Wei D, Tan D, Alasadi M, Zhang HC, Thomas A, Thomas AS, Richards DM, Wang Y. Clinical Characteristics and Outcomes of Patients with Positive Celiac Serology and Cancer Therapy Exposure. J Cancer 13(3):815-822, 2022. e-Pub 2022. PMID: 35154450.
- Abu-Sbeih H, Mallepally N, Goldstein R, Chen E, Tang T, Dike UK, Al-Asadi M, Westin S, Halperin D, Wang Y. Gastrointestinal toxic effects in patients with cancer receiving platinum-based therapy. J Cancer 11(11):3144-3150, 2020. e-Pub 2020. PMID: 32231718.
- Abu-Sbeih H, Tran CN, Ge PS, Bhutani MS, Alasadi M, Naing A, Jazaeri AA, Wang Y. Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment. J Immunother Cancer 3(7):118, 2019. e-Pub 2019. PMID: 31053161.
- Alkhatib AA, Alasadi M. Choledocholithiasis in Roux-en-Y gastric bypass patients. Am J Gastroenterol 113(5):776-777, 2018. PMID: 29453381.
- Waness A, Bismar MM, Alasadi M, Elmustafa N, Al Sharqi K, Al Kaabi EA, Almaslamani Y, Roemer H. Continuity of care challenges in GCC countries: H. Pylori eradication as Example in a UAE Tertiary Care Center. International Journal of Medical Science and Public Health 4(8):1125-1131, 2015. PMID: None.
- Bismar MM, Alasadi M, Hendawy BS, Waness A. A case of successful remission of extensive primary gastric diffuse large B cell lymphoma: radiologic, endoscopic and pathologic evidence. Case Rep Gastroenterol 8(1):134-40, 2014. e-Pub 2014. PMID: 24847196.
- Skoczlas T, Yandrapu H, Poplawski C, Mazen A, Wallner G, Sarosiek J. Salivary Bicarbonate as a Major Factor in the Prevention of Upper Esophageal Mucosal Injury in Gastroesophageal Reflux Disease. Dig Dis Sci 59:2411-2416, 2014. PMID: None.
- Alasadi M, Jameson F, Tawfik O. A case to remember: Hemangiopericytoma of The Liver: Report of a Case and Review of the Literature. Practical Gastroenterology Journal 26(3), 2002. PMID: None.
- Alasadi M, Bennett C, Tawfik O. A case to remember: Colonic Lipoma: An unusual Presentation With Intussusception and Obstruction. Practical Gastroenterology Journal 15(7), 2001. PMID: None.
- Wang YH, Alasadi M. Gastrointestinal toxic effects in patients with cancer receiving platinum-based therapy (the “Work). American Journal of Clinical Oncology. PMID: None.
Abstracts
- Alasadi M, Abu-Sbeih H, Bokhari RH, Shuttlesworth GA, Gonzalez GN, Lum PJ. Helicobacter Pylori Infection in Cancer Patients: MD Anderson Cancer Center Experience. ACG 2019-poster, 2019. PMID: None.
- Tran C, Abu-Sbeih H, Bhutani MS, Alasadi M, Ge PS, Wang Y. Can Cholecystitis be an adverse event from immune checkpoint inhibitor treatment?. DDW 2019 oral presentation, 2019. PMID: None.
- Alasadi M, Bismar M, Waness A. Cluster of Hematophagic Gut Worms: a Diversified Case Series. 5th Annual SEHA Research Conference, 2013. PMID: None.
- Alasadi M, Skozylas T, Poplawski C, McCallum R, Wallner G, Sarosiek J. Patients with Reflux Esophagitis Secrete More EGF inthe Proximal Than the Distal Segment of Esophagus: It’s Potential Pathogenetic Implication. American College of Gastroenterology Annual Meeting, 2004. PMID: None.
- Alasadi M, Poplawski C, Skoczylas T, Jaworski T, McCallum R, Sarosiek J. Glycoconjugate Component of the Esophageal Pre-Epithelial Defense in Patients With Reflux Esophagitis Is Significantly Impaired: Its Pathogenetic Implications. American College of Gastroenterology Annual Meeting, 2002. PMID: None.
- Alasadi M, Poplawski C, Skoczlas T, Sarosiek J. The Significantly Higher Content of Epidermal Growth factor within the Lower Esophageal Mucosa Could Be a Factor Preventing the Development of Mucosal Injury under Exposure to Gastroesophageal Reflux. American Gastroenterological Association Annual Meeting, 2002. PMID: None.
- Alasadi M, Poplawski C, Skoczylas T, McCallum R, Sarosiek J. The Upper Esophageal Mucosal Buffering Capacity In Patients With Reflux Esophagitis Is Significantly Impaired: Its Pathogenetic Implications. American Gastroenterological Association Annual Meeting, 2002. PMID: None.
- Alasadi M, Poplawski C, Skoczylas T, McCallum R, Sarosiek J. Salivary Bicarbonate Secretion, Mediated By The Esophago-Salivary Reflex In Patients With Reflux Esophagitis Is Significantly Impaired: Its Pathogenetic Implications. American Gastroenterological Association Annual Meeting, 2001. PMID: None.
- Alasadi M, Daaboul B, Raju GS, Crawford G, Hershberger J. Endoscopic Hemostasis: Clipping Of a Technically Challenging Arterial Spurter. American College of Gastroenterology Annual Meeting, 2000. PMID: None.
- Alasadi M, Poplawski C, Skoczylas T, McCallum R, Sarosiek J. An Impairment In Esophageal Glycoconjugate Secretion in Patients with Reflux Esophagitis Represents A Generalized Phenomenon Potentially Predisposing To the Development of Mucosal Injury. American College of Gastroenterology Annual Meeting, 2000. PMID: None.
- Alasadi M, Poplawski C, Skoczylas T, Loftiss M, SarosiekJ. A Strong Salivary Secretory Response, In Terms Of Prostaglandin E2, During the Upper Esophageal Mucosal Exposure to Acid and Pepsin Could Be A Factor in Prevention Of The Upper Esophageal Mucosal Injury during Gastroesophageal Reflux. American College of Gastroenterology Annual Meeting, 2000. PMID: None.
- Alasadi M, Skoczlas T, Kalahasthy K, Poplawski C, Loftiss M, Sarosiek I, Sarosiek J. The Qualitative and Quantitative Impairment In Salivary Esophagoprotection In Patients With Sjogren’s Syndrome: A Clinical Benefit of Mastication. American Gastroenterological Association annual meeting, 2000. PMID: None.
- Alasadi M, Poplawski C, Skoczylas T, Loftiss M, Sarosiek J. Significantly Higher SalivaryBicarbonate and Non-Bicarbonate Output During the Upper Esophageal Mucosal Exposure to Acid and Pepsin Could Be a Factor In Prevention of The Upper Esophageal Mucosal Injury During Gastro esophageal Reflux. American Gastroenterological Association annual meeting, 2000. PMID: None.
- Alasadi M, Poplawski C, Skoczylas T, Loftiss M, McCallum RW, Sarosiek J. The Difference in the Rate of Prostaglandin E2 Secretion withinthe Lower and the UpperEsophageal Mucosa: Its Potential Pathogenetic Implications. American Gastroenterological Association annual meeting, 2000. PMID: None.
- Alasadi M, Poplawski C, Marcinkiewicz M, Peura DA, Zbroch T, Sarosiek J. Significantly Elevated Prostaglandin E2 Content In Fasting Gastric Juice Of Patients With Non-Ulcer Dyspepsia: Is It A Culprit of Their Symptomatology?. American College of Gastroenterology annual meeting, 1999. PMID: None.
- Alasadi M, Poplawski C, Loftiss M, Kita A, McCallum RW, Sarosiek J. An Insight into the Upper and the Lower Esophageal Secretory Function: Its Potential Clinical Significance. American College of Gastroenterology annual meeting, 1999. PMID: None.
- Asadi M, Topalovski M, Sharma P, Weston AP. Prospective Multivariate Evaluation of cardia Intestinal Metaplasia. Poster presentation American Gastroenterologic Association Annual meeting, 1999. PMID: None.
- Alasadi M, Hiba MR, Daaboul B, Kyner JL, McCallum RW. Is There a Difference in the Prevalence of Gastrointestinal Symptoms between Type I and Type II Diabetics?. American Gastroenterological Association Annual meeting, 1999. PMID: None.
- Alasadi M, Poplawski C, Zbroch T, Weston AP, Brown R, Badr AS, Marcinkiewicz M, Sarosiek J. Smoking Status Affects The Content Of Mucin But Not Prostaglandins And Peptide Growth Factors In Gastric Juice: Its Potential Pathogenetic Implications. American Gastroenterological Association Annual meeting, 1999. PMID: None.
- Alasadi M, Hiba MR, Daaboul B, Kyner JL, McCallum RW. Quality Of Life In Diabetics Is substantially Affected By The High prevalence Of Gastrointestinal Symptoms. American Gastroenterological Association Annual meeting, 1999. PMID: None.
- Alasadi M, Poplawski C, Zbroch T, Weston AP, Brown R, Badr AS, Marcinkiewicz M, Serosiek J. Does Chronic Administration Of A Small Dose Of Non-Steroidal Anti-Inflammatory Drugs Affects Concentration Of Prostaglandin E2 And Peptide Growth Factors In fasting Gastric Juice? It’s Potential Diagnostic Implications. American Gastroenterological Association Annual meeting, 1999. PMID: None.
- Alasadi M, Hiba MR, Daaboul B, Kyner JL, McCallum RW. Prevalence of Gastro-Intestinal Symptoms In-Patients with Diabetes Mellitus: Comparison between Type I and Type II. Southern Society of Clinical Investigation meeting, 1999. PMID: None.
- Alasadi M, Hiba MR, Daaboul B, Kyner J, McCallum RW. Prevalence of GI Symptoms in Patients with Diabetes Mellitus. American College of Gastroenterology annual meeting, 1998. PMID: None.
Patient Reviews
CV information above last modified October 08, 2024